The Asia Pacific single-cell analysis market is projected to reach USD 1,375 million by 2025 from USD 550 million in 2020, at a CAGR of 20.1%. Asia Pacific single-cell analysis market growth is driven by the growing focus on personalized medicine, increasing R&D in the pharmaceutical and biotechnology industries for complex diseases, growth in stem cell research, and the increasing frequency of pandemics.
read more..